RBCGX
Price
$69.32
Change
+$0.52 (+0.76%)
Updated
Jun 2 closing price
Net Assets
69M
VIGAX
Price
$214.25
Change
+$1.43 (+0.67%)
Updated
Jun 2 closing price
Net Assets
269.26B
Interact to see
Advertisement

RBCGX vs VIGAX

Header iconRBCGX vs VIGAX Comparison
Open Charts RBCGX vs VIGAXBanner chart's image
Reynolds Blue Chip Growth
Price$69.32
Change+$0.52 (+0.76%)
VolumeN/A
Net Assets69M
Vanguard Growth Index Admiral
Price$214.25
Change+$1.43 (+0.67%)
VolumeN/A
Net Assets269.26B
RBCGX vs VIGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RBCGX vs. VIGAX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RBCGX is a Buy and VIGAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 269B vs. RBCGX (69M). VIGAX pays higher dividends than RBCGX: VIGAX (0.46) vs RBCGX (0.00). RBCGX was incepted earlier than VIGAX: RBCGX (37 years) vs VIGAX (25 years). RBCGX (2.01) is less costly to investors than VIGAX (0.05). RBCGX is a more actively managed with annual turnover of: 269.00 vs. VIGAX (11.00). RBCGX has a lower initial minimum investment than VIGAX: RBCGX (1000) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 17.83 vs. RBCGX (11.33). VIGAX return over 5 years is better than : 109.40 vs. RBCGX (20.72).
RBCGXVIGAXRBCGX / VIGAX
Total Expense Ratio2.010.054,020%
Annual Report Gross Expense Ratio2.010.054,020%
Fund Existence37 years25 years-
Gain YTD2.0320.758268%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets69M269B0%
Annual Yield % from dividends0.000.46-
Returns for 1 year11.3317.8364%
Returns for 3 years36.8670.0553%
Returns for 5 years20.72109.4019%
Returns for 10 years12.38281.474%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRK20.821.09
+5.52%
A-Mark Precious Metals
GTBP2.710.13
+5.04%
GT Biopharma
GBTG6.340.09
+1.44%
Global Business Travel Group
XP19.490.13
+0.67%
XP
XTNT0.66N/A
+0.09%
Xtant Medical Holdings